Showing results (1961-1970 of 2,089) with videos related to

Sort By:
Pageof 209
Open Research Europe|March 24, 2025
Micromegas with GEM preamplification for enhanced energy threshold in low-background gaseous time projection chambersJuan Francisco Castel Pablo, Susana Cebrián Guajardo, Theopisti Dafni, et al.
Science Advances|May 17, 2023
Mice with humanized livers reveal the role of hepatocyte clocks in rhythmic behaviorAnne-Sophie Delbès, Mar Quiñones, Cédric Gobet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2021
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group StudyAlberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, et al.
Brain : a Journal of Neurology|April 17, 2016
A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injurySandrine Delbary-Gossart, Sangmi Lee, Marco Baroni, et al.
Nature|March 9, 2018
Corrigendum: Landscape of X chromosome inactivation across human tissuesTaru Tukiainen, Alexandra-Chloé Villani, Angela Yen, et al.
Nature Genetics|April 8, 2014
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaKathryn R Taylor, Alan Mackay, Nathalène Truffaux, et al.
Med (New York, N.Y.)|October 19, 2020
A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom SurveysSaar Shoer, Tal Karady, Ayya Keshet, et al.
Journal of the American College of Cardiology|August 23, 2023
Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant RecipientsDavid Couto-Mallón, Luis Almenar-Bonet, Eduardo Barge-Caballero, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's diseaseDominique Lesuisse, André Malanda, Jean-François Peyronel, et al.
British Journal of Cancer|May 15, 2018
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma StudyAna P Berbegall, Dominik Bogen, Ulrike Pötschger, et al.
Pageof 209